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Abstract Capsaicin is the active ingredient in chili pepper
and has an inhibitory effect on Helicobacter pylori growth
and NF-κB activation. The present study examined the effect
of capsaicin on interleukin (IL)-8 production by H. pylori
ATCC 43504-infected MKN-45 cells, a gastric epithelial cell
line. The viability of the MKN-45 cells treated with capsaicin
at 0, 50, 100, 250, and 500 µM was 99, 98, 99, 99, and 85%,
respectively. A capsaicin concentration as low as 50 µM
significantly inhibited the IL-8 production induced by H.
pylori ATCC 43504 infection (43.2% of control) during 24 h
of incubation. However, low concentrations of capsaicin (50
and 100 µM) did not significantly inhibit the IL-8 production
by TNF-α- or PMA-treated MKN-45 cells. Therefore, the
overall inhibitory effect of capsaicin on H. pylori ATCC 43504
was the sum of H. pylori ATCC 43504 growth inhibition, host
cell survival, and NF-κB signal cascade inhibition. 
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Helicobacter pylori is a known causative agent of gastritis
and gastric cancer [3], and an increase of interleukin (IL)-8
has been shown in H. pylori-positive gastric mucosa and
KATO-III cells co-cultured with H. pylori in vitro [7]. IL-8
is a small (10 kDa) inducible proinflammatory peptide [28]
containing the neutrophil-activating amino acid motif glu-
leu-arg, which is a potent neutrophil chemoattractant [16]
that stimulates neutrophil migration along a chemotactic
gradient and modulates the expression of adhesion molecules
[17]. The infiltration of neutrophils into the mucosa is
already known to occur in H. pylori-induced chronic active
gastritis, plus activated neutrophils release proteases and
reactive oxygen metabolites that cause gastric mucosal
injury [8].
There are several natural compounds that actively inhibit
H. pylori. For example, the inhibitory effect of different
Bifidobacterium spp. on the growth of H. pylori has been
investigated and found to be caused by the bacteriocins
from Bifidobacterium spp. [2]. In addition, polyfermenticin
SCD, named tentatively as the bacteriocin produced by
Bacillus polyfermenticus SCD, has been shown to exhibit
antimicrobial activity against H. pylori KCTC 2948
growth [20]. Meanwhile, certain components of Ginseng,
polysaccharides, protopanaxadiol, and ponciretin have also
been reported to inhibit H. pylori growth and infection
in Kato-III cells and the Vac A vacuolation of HeLa
cells, although a single type of ginsenoside, polyacetylene,
or polysaccharide did not exhibit H. pylori inhibitory
activities [18, 19]. Furthermore, a polysaccharide isolated
from the leaves of Artemisia capillaries has also shown
inhibitory activities against H. pylori [31]. Hideki Masuda
et al. [21] have investigated the inhibitory effects of
Gochoonangi roots, stems, and leaves against the growth
of H. pylori and its urease activity.
Capsaicin is the active ingredient in chili pepper, and
several research groups have demonstrated the cytoprotective
effect of chili or capsaicin on experimentally induced gastric
injury in animal models. Pretreatment with capsaicin also
ameliorates aspirin-induced gastric lesions in rats [12].
Similarly, the acute and long-term administration of capsaicin
has been found to decrease the gastric injury in rats following
the consumption of ethanol [15]. Capsaicin and its analogs
are known to have growth inhibition effects on microorganisms
*Corresponding author
Phone: 82-2-450-3679; Fax: 82-2-455-1044;
E-mail: chhan@konkuk.ac.kr
INHIBITORY EFFECT OF CAPSAICIN ON IL-8 PRODUCTION 1079
such as Zygosaccharomyces rouxii KFY80 [25]. In addition,
capsaicin is already known to inhibit the growth of H.
pylori at 10 µg/ml in vitro with a maximal inhibitory
effect at a concentration of 50 µg/ml [14]. However, the
mechanism by which capsaicin reduces H. pylori-induced
gastric injury has not yet been determined.
Accordingly, in vitro time- and dose-dependent studies
were conducted to examine the production of IL-8, a key
player in gastric inflammatory processes, by the stomach
cancer cell line MKN-45 in the presence of H. pylori.
Upon H. pylori infection, the MKN-45 cells produced IL-8
in a time- and dose-dependent manner. However, this IL-8
induction was significantly inhibited by the addition of
capsaicin in a time- and dose-dependent manner. Since this
inhibitory effect of capsaicin on H. pylori may be related
to the suppression of the NF-κB activation induced
by H. pylori, as previously shown by Singh et al. [29], the
suppressive effect of capsaicin on the IL-8 production induced
by PMA or TNF-α was examined. The results suggested
that capsaicin partially inhibits the NF-κB activation induced
by H. pylori ATCC 43504, and thus could be used as a
potential target for drug development against H. pylori
ATCC 43504 infection.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Urease-positive, Vac A+, Cag A+ wild-type H. pylori
ATCC 43504 (Rockville, U.S.A.) was used. The bacteria
were grown on blood agar plates supplemented with 5%
sheep blood for 48 h at 37
o
C in a microaerobic system jar





generated by a Campy pak plus (BBL, Sparks, U.S.A.).
The H. pylori was inoculated onto a brain heart infusion
(BHI) medium containing 5% horse serum (pH 6.8) and
incubated for up to 2 days [35]. The optimal stimulation
concentration of H. pylori ATCC 43504 on the MKN-45
cells was 500 cfu/cell.
Gastric Epithelial Cell Line
The MKN-45 cells [10, 22], a human gastric cancer cell
line, were cultured in an RPMI-1640 medium (Gibco,
Grand Island, U.S.A.) with 10% heat-inactivated fetal calf
serum (Hyclone, Utah, U.S.A.). The cells were incubated
at 37
o
C in a humidified atmosphere with 5% CO
2
, then
passaged at subconfluence after trypsinization and seeded
into 6- or 24-well culture plates (Nunk, Denmark).
Reagents
PMA (Sigma, St. Louis, U.S.A.) and TNF-α (Pharmingen,
San Diego, U.S.A.) were used as the stimulators, and
capsaicin (Sigma, St. Louis, U.S.A.) as the inhibitor of the
IL-8 production by the stimulator-treated MKN-45 cells.
Cytotoxity of Capsaicin Towards H. pylori and MKN-45
The cytotoxic effect of capsaicin on the H. pylori ATCC
43504 and MKN-45 cells was assessed separately. The H.
pylori ATCC 43504 was cultured on blood agar plates with
capsaicin on paper disks for 4 days, and then the H. pylori
ATCC 43504 growth inhibition zones were measured.
Meanwhile, the MKN-45 cells were cultured in 96-well
plates with media containing various concentrations (1,000,
500, 250, 100, 50, 10, and 0 mM) of capsaicin for 48 h,
followed by an MTT assay.
IL-8 ELISA
After culturing the MKN-45 cells in 24-well plates overnight,
the cells were stimulated by H. pylori ATCC 43504 (500 cfu/
cell) and PMA (1 µg/ml) or TNF-α (100 unit/ml) in the
presence of various concentrations (250, 100, 50, and 0 mM)
of capsaicin for 2, 4, 8, 16, and 24 h, respectively. The
IL-8 concentrations in the culture supernatants were then
determined by an enzyme-linked immunosorbent assay
(ELISA). The wells of 96-well microtiter plates (Nunc
Inc., Denmark) were pre-coated with goat anti-human IL-8
antibody (R&D Systems 614, McKinley Place, U.S.A.,
4 µg/ml in 100 µl of PBS) by incubating overnight at
room temperature, washed with PBS containing 0.05%
Tween 20 and 0.1% BSA (Sigma, St. Louis, U.S.A.), and
blocked with 1% BSA in PBS-Tween 20 for 1 h at room
temperature. After a further washing, 100 µl of conditioned
media or IL-8 standards (R&D Systems, 614 Mckinley Place,
U.S.A.) was added and incubated at room temperature for
2 h. A rabbit anti-human IL-8 (1:1,000, Endogen, Woburn,
U.S.A.) primary antibody was then added to the wells at
room temperature for 1 h. Alkaline phosphatase conjugated
mouse anti-rabbit IgG (Jackson, West Growe, U.S.A.) was
used as the secondary antibody. An ELISA Amplification
System (Gibco, Grand Island, U.S.A.) was used to develop
the enzyme-catalyzed color dye production. The optical
density at 494 nm was read using an automated microplate
photometer, and the concentrations of IL-8 were determined
by comparison with the IL-8 standard curve.
RESULTS
Cytotoxicity of Capsaicin Towards H. pylori ATCC
43504 and MKN-45 Cells
The cyotoxic effect of capsaicin on H. pylori ATCC 43504
was measured based on the inhibition zone of H. pylori
ATCC 43504 growth, which was 0, 0, 12, and 32 mm with
0, 250, 500, and 1,000 µM of capsaicin, respectively. The
maximal inhibitory effect of capsaicin was at a concentration
of 1 mM, whereas the capsaicin concentration of 250 µM
had no inhibitory effect on the growth of H. pylori ATCC
43504. Incubation with the vehicle (DMSO) alone did not
affect the growth of the bacteria. In accordance with the
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findings of Jones et al. [14], bactericidal activity against H.
pylori ATCC 43504 was evident within 4 h of incubation
(data not shown). Meanwhile, when examining the cytotoxic
effect of capsaicin on the MKN-45 cells, a gastric epithelial
cell line, the MKN-45 cells were able to tolerated incubation
with up to 500 µM of capsaicin for a period of 24 h
(Fig. 1). The viability of the cells treated with 0, 50, 100,
250, and 500 µM of capsaicin was 99, 98, 99, 99, and
85%, respectively. A cytotoxic effect on the MKN-45
cells became evident after 48 h of incubation at capsaicin
concentrations of 250 µM (65% survival) and 500 µM (2%
survival), whereas a capsaicin concentration of 100 µM or
less had a minimal affect on the viability of the MKN-45
cells (data not shown).
Increased IL-8 Production by MKN-45 Cells Infected
with H. pylori ATCC 43504
The MKN-45 cells infected with H. pylori ATCC 43504
for 8 h released an increased amount of IL-8 into the
culture media (Fig. 2) and this effect was dose- and time-
dependent. The IL-8 production was significantly increased
after 2 h, and the highest IL-8 release was observed after
8 h at an infection ratio of 1:500 (host cell: H. pylori). No
further increase in IL-8 production was evident with
bacteria doses above 1:500.
Inhibition of H. pylori ATCC 43504-Induced IL-8
Production by MKN-45 Cells Treated with Capsaicin
The effect of capsaicin on the H. pylori ATCC 43504-
induced IL-8 production by the MKN-45 cells was examined.
A capsaicin concentration as low as 50 µM significantly
inhibited the IL-8 production induced by the H. pylori
ATCC 43504 infection (43.2% of control) after 24 h of
incubation (Fig. 3). The inhibitory effect of the capsaicin
became evident during the first 8 h of incubation and longer
exposure to capsaicin returned the IL-8 production to
baseline levels.
Partial Inhibition of TNF- and PKC-Dependent IL-8
Production by MKN-45 Cells Treated with Capsaicin
The experimental findings presented here are consistent
with previous studies showing that H. pylori ATCC 43504
infection induces IL-8 production. The promoter region of
the IL-8 gene carries a putative NF-κB binding site, and
this transcription factor is believed to be a prime regulatory
element for IL-8 expression. Thus, the ability of capsaicin
to suppress the IL-8 production by H. pylori ATCC 43504-
infected cells suggests that capsaicin may inhibit the
NF-kB in gastric epithelial cells. Therefore, the effect of
capsaicin on other NF-κB activating signals, specifically
TNF-α and PMA, was examined. In contrast to the H. pylori
ATCC 43504-infected MKN-45 cells, low concentrations
of capsaicin (50 and 100 µM) did not significantly inhibit
the IL-8 production by the TNF-α- or PMA-treated
MKN-45 cells (Fig. 4), which is consistent with previous
Fig. 1. Viability of MKN-45 cells at various concentrations of
capsaicin followed by MTT assay.
Fig. 2. Effect of MKN-45 cell IL-8 release by H. pylori ATCC
43504 infection.
Each measurement is from three replicates. Symbols used: ▤, 1 h; ▧, 2 h;
□ , 4 h; ■ , 8 h.
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studies [27]. However, a 250 µM concentration of capsaicin
significantly suppressed the IL-8 production by the TNF-α-
or PMA-treated MKN-45 cells, suggesting that capsaicin
interferes with the TNF-α- and PMA-signal cascades leading
to IL-8 expression via NF-κB.
DISCUSSION
IL-8 is an important cytokine in the host inflammatory
response to H. pylori [22, 26], which correlates with its
induction in gastric epithelial cells co-cultured with H.
pylori in vitro [6, 27]. A variety of studies have shown
that the gastric epithelium is an important source of
chemokines [5, 10], which are released both in response to
H. pylori [1, 27] and on exposure to endogenous pro-
inflammatory mediators [33]. The bacterial induction of
epithelial chemokines involves a protein tyrosine kinase
(PTK) pathway and NF-κB activation [1]. The upregulation
of IL-8 by H. pylori may lead to free-radical generation
and the release of proteolytic enzymes from activated
neutrophils, affecting mucosal integrity [34]. The eradication
of H. pylori in ulcer patients results in a reduction of antral
IL-8 mRNA expression, neutrophil infiltration, and surface
epithelial lesions [22], suggesting that inflammatory cytokines
may play an important role in the mucosal damage seen
with H. pylori infection. Therefore, this study investigated
the hypothesis that the production of IL-8 by gastric
MKN-45 cells exposed to H. pylori, TNF-α, and PMA is
diminished by capsaicin treatment. H. pylori significantly
enhanced the production of IL-8 from the gastric epithelial
cell line MKN-45. Capsaicin then exerted an inhibitory
effect on the IL-8 production by the MKN-45 cells when
co-cultured with H. pylori ATCC 43504, in accordance
Fig. 3. Time course of IL-8 release by capsaicin-treated MKN-
45 cells exposed to H. pylori ATCC 43504.
The MKN-45 cell monolayers were infected with H. pylori ATCC 43504
(1:500) and treated with various concentrations (0, 50, 100, and 250 µM)
of capsaicin. Each measurement is from three replicates. Symbols used: ■ ,
0 µM; □ , 50 µM; ●, 100 µM; ○ , 250 µM.
Fig. 4. Time course of IL-8 release by capsaicin-treated MKN-
45 cells exposed to TNF-α and PMA.
The MKN-45 cell monolayers were stimulated with 100 units/ml of TNF-
α (A) and 1 µg/ml of PMA (B), and treated with various concentrations (0,
50, 100, and 250 µM) of capsaicin. Each measurement is from three
replicates. Symbols used: ■ , 0 µM; □ , 50 µM; ●, 100 µM; ○ , 250 µM.
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with the findings of Kassai et al. [16]. The inhibitory effect
of capsaicin on the IL-8 production induced by H. pylori
ATCC 43504 infection became evident after as little as 8 h
of incubation, suggesting that the penetration of capsaicin was
the limiting factor. Once capsaicin reached its intracellular
(cytoplasmic) target(s), the suppressed activation remained
stable thereafter.
Since TNF-α and PMA are potent activators of IL-8
expression by epithelial cells via NF-κB, the present study
then tested the effect of capsaicin on IL-8 production
by MKN-45 cells stimulated with these agents. The data
revealed that capsaicin effectively inhibited in a time- and
concentration-dependent manner the IL-8 production by
MKN-45 cells co-cultured with H. pylori ATCC 43504,
TNF-α, and PMA in vitro, suggesting that capsaicin may
interfere with the signal cascades of PMA, TNF-α, and H.
pylori ATCC 43504 that lead to the expression of IL-8.
The primary signal cascade candidate affected by capsaicin
is the NF-κB pathway, as PMA, TNF-α, and H. pylori are
all known to utilize the NF-κB signaling pathway to induce
IL-8 expression [13]. In addition, the finding that H. pylori
is a potent activator of NF-κB also supports this idea, since
other NF-κB responsive genes, including TNF-α, IL-1, and
IL-6, have been found to be elevated in the gastric mucosa
of persons with H. pylori [9, 24]. Furthermore, the production
of IL-8 in AGS gastric cells by H. pylori is regulated via an
NF-κB-dependent transcriptional process [13]. In the present
study, low concentrations (50 µM and 100 µM) of capsaicin
did not significantly inhibit the production of IL-8 by PMA-
and TNF-α-stimulated cells, which is in accordance with
the previous study of Singh et al. [29], where capsaicin
(300 µM) failed to suppress NF-κB activation by TNF-α
unless the cells were pretreated. However, high doses of
capsaicin (250 mM) consistently inhibited the IL-8 production
induced by TNF-α and PMA treatment up to 90%. At this
point, the reason for this discrepancy is uncertain and
under investigation using various cell lines.
Capsaicin is known to block both the degradation of
IκBα and the nuclear translocation of the p65 subunit of
NF-κB [4, 29]. Similar to capsaicin, 1-O-octadecyl-2-O-
methyl-rac-glycero-3-phosphocholine, a synthetic diester
phospholipid, and auranofin, an antirheumatic drug, have
reported to inhibit PMA-induced NF-κB activation, yet
not TNF-α- or IL-1-induced NF-κB activation [32]. Although
PMA and capsaicin both activate PKC, only PKC induces
NF-κB [30], as shown by the IL-8 production by the
MKN-45 cells in the present study. Thus, although capsaicin
had no effect on NF-κB activation, it blocked PMA-induced
NF-κB activation. Similar to TNF, PMA is also known
to generate Reactive Oxygen I, which may play a critical
role in the effect of capsaicin on PMA [30]. In addition
to inhibiting the growth of H. pylori in vitro, capsaicin has also
exhibited specific bactericidal activity against a nonpathogenic
human commensal E. coli strain. In addition, capsaicin
continues to exhibit antibacterial activity at reduced pH
values, suggesting that the efficacy of capsaicin may be
independent of pH [14]. In accordance with these findings,
the present data also showed similar effects of capsaicin.
However, in contrast to previous findings, the minimum
dose affecting H. pylori ATCC 43504 growth was 500 µM,
which is a lethal dose for the cells tested. Nonetheless,
capsaicin inhibited the production of IL-8 by H. pylori-
stimulated MKN-45 cells at concentrations as low as
250 µM with minimal effect on the cell survival. Thus, the
present data revealed that capsaicin exerted an inhibitory
effect on the IL-8 production by MKN-45 cells stimulated
by H. pylori ATCC 43504, confirming that the inhibitory
effect was not due to the growth inhibition of the MKN-45
cells, but rather to the inhibition of IL-8 production by the
H. pylori-stimulated MKN-45 cells and H. pylori ATCC
43504 growth.
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